Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133307) titled 'A Randomized Controlled Trial of Digital Intelligence-Based MACE Risk Prediction and Proactive Health Management Among Patients with Chronic Diseases' on Sept. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Guangzhou University of Chinese Medicine Jun'an, Guangdong Hospital of Shunde Hospital (Jun an hospital, Shunde District, Foshan)
Condition:
Major adverse cardiovascular events (MACE), including non-fatal myocardial infarction, non-fatal stroke, cardiovascular death, heart failure and unstable angina pectoris
Intervention:
Intervention group:CVDGPT APP intelligent health...